Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



Yaz Birth Control Pill is Approved for Prementrual Dysphoric Disorder


Posted on 2006-10-05 15:59:00



Berlex Inc., a U.S. unit of German drug maker Schering AG, said Thursday that the Food and Drug Administration approved its Yaz birth control pill for the treatment of premenstrual dysphoric disorder as well.

The FDA approved Yas for birth control in March. Premenstrual dysphoric disorder occurs when a woman's premenstrual symptoms significantly disrupt her daily life. Symptoms, which begins about 10 days before the onset of period, include mood swings, irritability, headaches, feeling anxious, bloating and food cravings.

An estimated 4.5 million women in the United States suffer from the condition and about 90 percent of those are undiagnosed and untreated, Berlex said.


NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP